Company has promise, no doubt about that. If this thing ever makes a break-out move, can't imagine how high it may go. Nonetheless, the stock is still a lottery ticket type investment. Their patent protection over Rose Bengal concerns me most. Not sure what type of `moat' they have for legal protection. Even if Rose Bengal is proven to be a highly effective (which I believe it will be proven to be), what prevents other BP's to just make clinical grade generic PV10 themselves?
The many potential uses of this beneficial drug is so impressive, for patient and investor sakes, I hope they are successful.